FDA Approved: NITYR — Original Application (Cycle Pharmaceuticals Ltd.)

View source ↗

Summary

The FDA approved NITYR (Nitisinone) as an original NDA from Cycle Pharmaceuticals Ltd. for the treatment of hereditary tyrosinemia type I.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Tyrosinemia Type

Drugs mentioned

• NITYR (Nitisinone)

Snippet

ORIG AP for NITYR (NITISINONE)